Supplementary Table 3 from Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations

Authors

Yasmeen Q. Rizvi (ORCID: https://orcid.org/0009-0000-2719-4093)
Kurt W. Evans (ORCID: https://orcid.org/0009-0008-6823-6809)
Timothy P. DiPeri (ORCID: https://orcid.org/0000-0003-1190-1640)
Argun Akçakanat (ORCID: https://orcid.org/0000-0002-4012-9840)
Antje M. Wengner (ORCID: https://orcid.org/0009-0009-5772-1945)
Timothy Anthony Yap (ORCID: https://orcid.org/0000-0002-2154-3309)
Maria Gabriela Raso (ORCID: https://orcid.org/0000-0003-2105-5556)
Funda Meric‐Bernstam (ORCID: https://orcid.org/0000-0001-6816-6072)
Dhruv Chachad (ORCID: https://orcid.org/0000-0003-3131-7679)
Kaushik Varadarajan (ORCID: https://orcid.org/0000-0002-4114-5498)
Christian X. Cruz Pico (ORCID: https://orcid.org/0000-0002-5620-7727)
Stephen M. Scott